Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Agents that elevate cAMP stimulate DNA fragmentation in thymocytes.

D J McConkey1, S Orrenius, M Jondal

  • 1Department of Toxicology, Karolinska Institutet, Stockholm, Sweden.

Journal of Immunology (Baltimore, Md. : 1950)
|August 15, 1990
PubMed
Summary

Elevated cyclic AMP (cAMP) levels induce apoptosis, or programmed cell death, in thymocytes. This process, mediated by protein kinase A, may be crucial for developing mature T lymphocytes and self-tolerance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Erratum to "Higher T-cell imbalance and growth factor receptor expression in B-cell chronic lymphocytic leukemia (B-CLL) as compared to monoclonal B-cell lymphocytosis of undetermined significance (B-MLUS)" [Leukemia Res. 13(1) (1989) 31-37].

Leukemia research·2017
Same author

Effect of ligand-activated estrogen receptor β on lymphoma growth in vitro and in vivo.

Leukemia·2011
Same author

Marizomib, a proteasome inhibitor for all seasons: preclinical profile and a framework for clinical trials.

Current cancer drug targets·2011
Same author

Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells.

Oncogene·2009
Same author

TLR9 activation increases TAP-independent vesicular MHC class I processing in vivo.

Scandinavian journal of immunology·2009
Same author

Measuring soluble forms of extracellular cytokeratin 18 identifies both apoptotic and necrotic mechanisms of cell death produced by adenoviral-mediated interferon alpha: possible use as a surrogate marker.

Cancer gene therapy·2009

Area of Science:

  • Immunology
  • Cell Biology
  • Molecular Biology

Background:

  • Cyclic AMP (cAMP) signaling can inhibit mature T lymphocytes and contribute to self-antigen tolerance.
  • Apoptosis, a programmed cell death pathway, is critical for immune system development, particularly in the thymus.

Purpose of the Study:

  • To investigate the role of cAMP in inducing apoptosis in thymocytes.
  • To explore the signaling pathways involved in cAMP-mediated thymocyte apoptosis.
  • To examine the interaction between cAMP and other signaling pathways in T cell development.

Main Methods:

  • Treatment of isolated thymocytes with agents that increase cAMP levels.
  • Assessment of DNA fragmentation as a marker of apoptosis.
  • Use of cAMP analogs to investigate protein kinase A activation.

Related Experiment Videos

  • Evaluation of the effects of protein kinase C activators (e.g., IL-1) on cAMP-induced apoptosis.
  • Main Results:

    • Agents increasing cAMP levels stimulated DNA fragmentation in thymocytes, indicating apoptosis induction.
    • Protein kinase A, activated by synergistic cAMP analogs, directly mediated endonuclease activation.
    • Protein kinase C activators blocked cAMP-induced DNA fragmentation and cell death, suggesting cross-talk between kinase pathways.
    • These findings highlight an interplay between protein kinase A and C in regulating thymocyte apoptosis.

    Conclusions:

    • Cyclic AMP (cAMP) plays a significant role in inducing apoptosis in thymocytes.
    • The cAMP-mediated apoptosis pathway involves protein kinase A and endonuclease activation.
    • Interactions between cAMP/protein kinase A and protein kinase C pathways influence thymocyte survival and death.
    • cAMP may be a key factor in the thymus's negative selection process, contributing to the development of functional mature T lymphocytes and self-tolerance.